Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1009 | 900 | 1009 | 939 | - | - |
Fund Return | 0.9% | -10.04% | 0.9% | -2.08% | - | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0171289225 | 1.07B | 21.36 | 8.23 | 7.10 | ||
LU0331284793 | 362.28M | 7.46 | -0.44 | 3.38 | ||
Global Allocation Fund X2 Use | 870.29M | 10.70 | 2.55 | 6.48 | ||
LU0408221512 | 1.31B | 8.83 | 0.81 | 4.68 | ||
LU0523293024 | 1.15B | 9.65 | 1.57 | 5.46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 70.07B | 15.41 | 9.09 | 7.73 | ||
Invesco JapEqAdvantage C EUR H AccE | 70.07B | 16.34 | 10.03 | 8.58 | ||
LU1482751903 | 481.64M | 19.62 | 9.30 | - | ||
LU1841614867 | 276.67M | 18.68 | 8.34 | - | ||
Morgan Stanley Global Brands CH | 20.87B | 5.17 | -2.52 | 6.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.54 | 808.90 | +0.60% | |
Boston Scientific | US1011371077 | 5.75 | 103.66 | +0.92% | |
AbbVie | US00287Y1091 | 5.56 | 175.73 | +0.27% | |
Intuitive Surgical | US46120E6023 | 4.36 | 582.25 | +1.66% | |
AstraZeneca | GB0009895292 | 4.01 | 11,320.0 | +0.78% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Strong Buy | BUY |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review